Form 8-K - Current report:
SEC Accession No. 0001641172-25-006026
Filing Date
2025-04-24
Accepted
2025-04-24 17:00:08
Documents
16
Period of Report
2025-04-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.03: Bankruptcy or Receivership
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 58330
2 ex99-1.htm EX-99.1 170768
3 ex99-1_001.jpg GRAPHIC 15996
4 ex99-1_002.jpg GRAPHIC 14446
  Complete submission text file 0001641172-25-006026.txt   473277

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE mtem-20250420.xsd EX-101.SCH 3003
6 XBRL LABEL FILE mtem-20250420_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE mtem-20250420_pre.xml EX-101.PRE 24157
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3582
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

EIN.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 25868723
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)